TY - JOUR
T1 - Is boric acid toxic to reproduction in humans? Assessment of the animal reproductive toxicity data and epidemiological study results
AU - Duydu, Yalçın
AU - Başaran, Nurşen
AU - Üstündağ, Aylin
AU - Aydın, Sevtap
AU - Ündeğer, Ülkü
AU - Ataman, Osman Yavuz
AU - Aydos, Kaan
AU - Düker, Yalçın
AU - Ickstadt, Katja
AU - Waltrup, Brita Schulze
AU - Golka, Klaus
AU - Bolt, Hermann Maximilian
N1 - Publisher Copyright:
© 2016 Bentham Science Publishers.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Boric acid and sodium borates are classified as toxic to reproduction in the CLP Regulation under “Category 1B” with the hazard statement of “H360FD”. This classification is based on the reprotoxic effects of boric acid and sodium borates in animal experiments at high doses. However, boron mediated reprotoxic effects have not been proven in epidemiological studies so far. The epidemiological study performed in Bandırma boric acid production plant is the most comprehensive published study in this field with 204 voluntarily participated male workers. Sperm quality parameters (sperm morphology, concentration and motility parameters), FSH, LH and testosterone levels were determined in all participated employees as the reproductive toxicity biomarkers of males. However, boron mediated unfavorable effects on reproduction in male workers have not been determined even in the workers under very high daily boron exposure (0.21 mg B/kg-bw/day) conditions. The NOAEL for rat reproductive toxicity is equivalent to a blood boron level of 2020 ng/g. This level is higher than the mean blood boron concentration (223.89 ± 69.49 ng/g) of the high exposure group workers in Bandırma boric acid production plant (Turkey) by a factor of 9. Accordingly, classifying boric acid and sodium borates under “Category 1B” as “presumed reproductive human toxicant in the CLP regulation seems scientifically not reasonable. The results of the epidemiological studies (including the study performed in China) support for a down-classification of boric acid from the category 1B, H360FD to category 2, H361d, (suspected of damaging the unborn child).
AB - Boric acid and sodium borates are classified as toxic to reproduction in the CLP Regulation under “Category 1B” with the hazard statement of “H360FD”. This classification is based on the reprotoxic effects of boric acid and sodium borates in animal experiments at high doses. However, boron mediated reprotoxic effects have not been proven in epidemiological studies so far. The epidemiological study performed in Bandırma boric acid production plant is the most comprehensive published study in this field with 204 voluntarily participated male workers. Sperm quality parameters (sperm morphology, concentration and motility parameters), FSH, LH and testosterone levels were determined in all participated employees as the reproductive toxicity biomarkers of males. However, boron mediated unfavorable effects on reproduction in male workers have not been determined even in the workers under very high daily boron exposure (0.21 mg B/kg-bw/day) conditions. The NOAEL for rat reproductive toxicity is equivalent to a blood boron level of 2020 ng/g. This level is higher than the mean blood boron concentration (223.89 ± 69.49 ng/g) of the high exposure group workers in Bandırma boric acid production plant (Turkey) by a factor of 9. Accordingly, classifying boric acid and sodium borates under “Category 1B” as “presumed reproductive human toxicant in the CLP regulation seems scientifically not reasonable. The results of the epidemiological studies (including the study performed in China) support for a down-classification of boric acid from the category 1B, H360FD to category 2, H361d, (suspected of damaging the unborn child).
KW - Boron exposure
KW - Developmental toxicity
KW - Reproductive toxicity
KW - Sperm quality parameters
UR - https://www.scopus.com/pages/publications/84973649583
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000384799700004&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.2174/1567201812666151029101514
DO - 10.2174/1567201812666151029101514
M3 - Article
C2 - 26511087
AN - SCOPUS:84973649583
SN - 1567-2018
VL - 13
SP - 324
EP - 329
JO - Current Drug Delivery
JF - Current Drug Delivery
IS - 3
ER -